Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology · 2026
The diagnostic utility of abdominal and bowel ultrasound in detecting gastrointestinal and hepatic manifestations of rheumatoid arthritis.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Atef Mira, Abdalaziz Rash Ahmed, Badry Ahmed, Darweesh Hanan, Razik Mohammed Mostafa Abdel, Ramadan Hala, Gaber Yasmin
Аннотация
BACKGROUND AND STUDY AIMS: Patients with Rheumatoid arthritis (RA) may develop digestive and hepatic complications. Abdominal ultrasound is sensitive to assess bowel abnormalities. We aimed to evaluate the frequency of gastrointestinal (GI) and hepatic disorders in RA patients and study the reliability of abdominal ultrasound in detecting these disorders to allow early management and better prognosis.
PATIENTS AND METHODS: 70 RA patients and 70 non-RA people as a reference control group were included in this study. Both study groups were subjected to the Rome IV criteria, the gastroesophageal reflux disease questionnaire, and trans-abdominal ultrasound. Transient elastography was done for subjects with bright or bright coarse liver on ultrasound.
RESULTS: Irritable bowel syndrome (IBS) and Gastroesophageal reflux disease (GERD) were statistically significantly higher in RA patients (28.5% and 51.4% respectively) than in the non-RA group (11.4% and 12.8% respectively) (p value = 0.019 and 0.000 respectively). Bright or bright coarse liver was statistically significantly higher in RA patients than in the non-RA group (p value = 0.000) and was statistically significantly higher in RA patients on methotrexate-based therapy (p value = 0.012). Only 2 RA patients (5.4%) had significant fibrosis (≥F2).
CONCLUSION: Abdominal ultrasound is recommended in the routine evaluation of the liver besides liver enzymes while bowel ultrasound is not recommended as routine screening in RA patients in the absence of complaint.
PATIENTS AND METHODS: 70 RA patients and 70 non-RA people as a reference control group were included in this study. Both study groups were subjected to the Rome IV criteria, the gastroesophageal reflux disease questionnaire, and trans-abdominal ultrasound. Transient elastography was done for subjects with bright or bright coarse liver on ultrasound.
RESULTS: Irritable bowel syndrome (IBS) and Gastroesophageal reflux disease (GERD) were statistically significantly higher in RA patients (28.5% and 51.4% respectively) than in the non-RA group (11.4% and 12.8% respectively) (p value = 0.019 and 0.000 respectively). Bright or bright coarse liver was statistically significantly higher in RA patients than in the non-RA group (p value = 0.000) and was statistically significantly higher in RA patients on methotrexate-based therapy (p value = 0.012). Only 2 RA patients (5.4%) had significant fibrosis (≥F2).
CONCLUSION: Abdominal ultrasound is recommended in the routine evaluation of the liver besides liver enzymes while bowel ultrasound is not recommended as routine screening in RA patients in the absence of complaint.